Published in Gastroenterology on March 27, 2010
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52
Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol (2010) 1.95
Genetic risk factors for pancreatic disorders. Gastroenterology (2013) 1.73
IgG4-related sclerosing disease, an emerging entity: a review of a multi-system disease. Yonsei Med J (2012) 1.26
IgG4- related disease: an orphan disease with many faces. Orphanet J Rare Dis (2014) 1.17
Autoimmune pancreatitis and IgG4-related systemic diseases. Int J Clin Exp Pathol (2010) 1.14
Two clinicopathologic subtypes of autoimmune pancreatitis: LPSP and IDCP. Gastroenterology (2010) 1.14
Strategy to differentiate autoimmune pancreatitis from pancreas cancer. World J Gastroenterol (2012) 1.12
Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am J Gastroenterol (2014) 1.11
Type 1 autoimmune pancreatitis. Orphanet J Rare Dis (2011) 1.10
Autoimmune pancreatitis complicated with inflammatory bowel disease and comparative study of type 1 and type 2 autoimmune pancreatitis. J Gastroenterol (2014) 1.02
Pathophysiology of chronic pancreatitis. World J Gastroenterol (2013) 0.99
Toll-like receptor activation in basophils contributes to the development of IgG4-related disease. J Gastroenterol (2012) 0.98
[IgG4-related disease]. Z Rheumatol (2013) 0.97
Review of the diagnosis, classification and management of autoimmune pancreatitis. World J Gastrointest Pathophysiol (2014) 0.95
IgG4-associated cholangitis with cholangiocarcinoma. Virchows Arch (2011) 0.93
Recent advances in autoimmune pancreatitis. Front Physiol (2012) 0.92
Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids. J Gastroenterol (2011) 0.90
Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis. United European Gastroenterol J (2013) 0.87
Autoimmune Pancreatitis: A Multiorgan Disease Presenting a Conundrum for Clinicians in the West. Gastroenterol Hepatol (N Y) (2015) 0.87
Recent advances in the diagnosis and management of autoimmune pancreatitis: similarities and differences in Japan and Korea. Gut Liver (2013) 0.86
A practical approach to the diagnosis of autoimmune pancreatitis. World J Gastroenterol (2011) 0.86
Clinical Characteristics of Patients with Autoimmune Pancreatitis with or without Mikulicz's Disease and Mikulicz's Disease Alone. Gut Liver (2012) 0.85
IgG4 related disease - a retrospective descriptive study highlighting Canadian experiences in diagnosis and management. BMC Gastroenterol (2013) 0.84
Clinical and pathological differences between serum immunoglobulin G4-positive and -negative type 1 autoimmune pancreatitis. World J Gastroenterol (2013) 0.83
IgG4-related disease: a new kid on the block or an old aquaintance? United European Gastroenterol J (2014) 0.83
A case of pancreatic cancer in the setting of autoimmune pancreatitis with nondiagnostic serum markers. Case Rep Surg (2013) 0.83
Rituximab for the treatment of IgG4-related orbital disease: experience from five cases. Eye (Lond) (2014) 0.82
Diagnosis of autoimmune pancreatitis. World J Gastroenterol (2014) 0.81
Multiple gene mutations in patients with type 2 autoimmune pancreatitis and its clinical features. Cent Eur J Immunol (2014) 0.81
Treatment of autoimmune pancreatitis with the anecdotes of the first report. Int J Rheumatol (2012) 0.79
Diagnosis and Treatment of Autoimmune Pancreatitis in China: A Systematic Review. PLoS One (2015) 0.79
Differentiating autoimmune pancreatitis from pancreatic adenocarcinoma using dual-phase computed tomography. J Comput Assist Tomogr (2014) 0.79
Azathioprine Maintenance Therapy to Prevent Relapses in Autoimmune Pancreatitis. Clin Transl Gastroenterol (2017) 0.78
Relapse of IgG4-related sclerosing cholangitis after steroid therapy: image findings and risk factors. Eur Radiol (2014) 0.78
Capability and limitations of recent diagnostic criteria for autoimmune pancreatitis. Int J Rheumatol (2013) 0.78
A Patient with Autoimmune Pancreatitis Type 1 with Previously Known Lymphadenopathy, Both in the Context of IgG4-related Disease. Am J Case Rep (2015) 0.77
Newly developed autoimmune cholangitis without relapse of autoimmune pancreatitis after discontinuing prednisolone. World J Gastroenterol (2012) 0.77
Immunoglobulin G4-related pancreatic and biliary diseases. Can J Gastroenterol (2013) 0.77
Chronic pancreatitis. Curr Opin Gastroenterol (2011) 0.77
Differences between diffuse and focal autoimmune pancreatitis. World J Gastroenterol (2012) 0.76
Poor response of initial steroid therapy for IgG4-related sclerosing cholangitis with multiple organs affected. Medicine (Baltimore) (2017) 0.75
Autoimmune Pancreatitis: A Case of Atypical Radiographic Findings. Case Rep Gastroenterol (2016) 0.75
Ulcerative colitis and immunoglobulin G4. Gut Liver (2013) 0.75
Follicular pancreatitis: a distinct form of chronic pancreatitis-an additional mimic of pancreatic neoplasms. Hum Pathol (2015) 0.75
Localized (18)F-fluorodeoxyglucose uptake at the pancreatic head during remission phase of autoimmune pancreatitis: A case report. Oncol Lett (2016) 0.75
Deciphering autoimmune pancreatitis, a great mimicker: case report and review of the literature. Case Rep Gastrointest Med (2015) 0.75
What's unique about acute pancreatitis in children: risk factors, diagnosis and management. Nat Rev Gastroenterol Hepatol (2017) 0.75
Rare case of Helicobacter pylori-positive multiorgan IgG4-related disease and gastric cancer. World J Gastroenterol (2015) 0.75
Long-term outcomes of autoimmune pancreatitis. World J Gastroenterol (2016) 0.75
A non-invasive screening technique for type 1 autoimmune pancreatitis. Wideochir Inne Tech Maloinwazyjne (2014) 0.75
Autoimmune pancreatitis and cholangitis. World J Gastrointest Pharmacol Ther (2015) 0.75
IgG4-Seronegative Autoimmune Pancreatitis and Sclerosing Cholangitis. Case Rep Gastrointest Med (2015) 0.75
Autoimmune Pancreatitis. Gastroenterol Rep (2013) 0.75
IgG4-related autoimmune pancreatitis overlapping with Mikulicz's disease and lymphadenitis: a case report. World J Gastroenterol (2013) 0.75
Early pancreatic volume reduction on CT predicts relapse in patients with type 1 autoimmune pancreatitis treated with steroids. Orphanet J Rare Dis (2016) 0.75
Outcome and Genetic Factors in IgG4-Associated Autoimmune Pancreatitis and Cholangitis: A Single Center Experience. Gastroenterol Res Pract (2017) 0.75
A rare case of IgG4-related systemic disease manifesting with pancreatic head mass mimicking borderline resectable cancer. Int J Surg Case Rep (2014) 0.75
Simultaneous occurrence of autoimmune pancreatitis and pancreatic cancer in patients resected for focal pancreatic mass. World J Gastroenterol (2017) 0.75
Coronary periarteritis in a patient with multi-organ IgG4-related disease. J Radiol Case Rep (2015) 0.75
Diagnosis and Management of Autoimmune Pancreatitis. Curr Treat Options Gastroenterol (2017) 0.75
Autoimmune Pancreatitis. Dig Dis Sci (2017) 0.75
Editorial: Autoimmune Pancreatitis in Children: Is This a New Subtype of Disease or Early-Onset Idiopathic Duct-Centric Chronic Pancreatitis? Am J Gastroenterol (2017) 0.75
[Bilateral chronic dacryoadenitis]. Z Rheumatol (2013) 0.75
The B73 maize genome: complexity, diversity, and dynamics. Science (2009) 18.73
Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01
Quality indicators for colonoscopy. Am J Gastroenterol (2006) 6.51
Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology (2010) 5.00
Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol (2006) 4.70
International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas (2011) 4.56
Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology (2007) 4.33
A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc (2010) 4.26
Quality indicators for colonoscopy. Gastrointest Endosc (2006) 3.83
Self-expanding plastic stents in treatment of benign esophageal conditions. Gastrointest Endosc (2007) 3.59
Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol (2003) 3.36
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol (2009) 3.26
Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology (2004) 3.25
Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). J Clin Oncol (2008) 3.15
Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients. Clin Gastroenterol Hepatol (2007) 3.14
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol (2009) 2.92
Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology (2006) 2.87
Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Ann Surg Oncol (2007) 2.82
Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology (2002) 2.76
Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol (2007) 2.73
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology (2012) 2.69
Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg (2008) 2.66
Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation. Liver Transpl (2015) 2.63
EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc (2007) 2.61
Establishing a true assessment of endoscopic competence in ERCP during training and beyond: a single-operator learning curve for deep biliary cannulation in patients with native papillary anatomy. Gastrointest Endosc (2007) 2.60
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology (2008) 2.58
Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol (2009) 2.55
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52
Retracted Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy. J Clin Oncol (2010) 2.49
The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology (2011) 2.42
AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. Carcinogenesis (2002) 2.41
Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst (2010) 2.38
Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. Radiology (2012) 2.35
Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology (2003) 2.35
Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg (2007) 2.35
Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol (2009) 2.35
ASGE Technology Status Evaluation Report: wireless capsule endoscopy. Gastrointest Endosc (2006) 2.30
Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology (2011) 2.30
Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos). Gastrointest Endosc (2011) 2.30
Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc (2008) 2.30
Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut (2010) 2.29
Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int (2012) 2.28
A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol (2004) 2.23
Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis. Curr Opin Rheumatol (2011) 2.17
EUS-guided biliary drainage for patients with malignant biliary obstruction with an indwelling duodenal stent (with videos). Gastrointest Endosc (2012) 2.15
Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis. Am J Gastroenterol (2007) 2.15
Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol (2007) 2.14
A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery (2005) 2.10
Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol (2012) 2.09
A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol (2009) 2.06